Nasdaq:US$15.83 (+0.59) | HKEX:HK$25.05 (+0.65) | AIM:£2.60 (+0.07)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate